Vivos Therapeutics, Inc. VVOS Q3 2025 earnings

FAQ

When did Vivos Therapeutics, Inc. report Q3 2025 earnings?

Vivos Therapeutics, Inc. (VVOS) reported Q3 2025 earnings on November 19, 2025 before market open.

What were Vivos Therapeutics, Inc.'s Q3 2025 revenue and EPS?

Vivos Therapeutics, Inc. reported revenue of $6.8M and eps of $-0.49 for Q3 2025.

Did Vivos Therapeutics, Inc. beat estimates in Q3 2025?

Revenue missed the consensus estimate of $7.1M by $313.7K. EPS beat the consensus estimate of $-0.53 by $0.04.

How did Vivos Therapeutics, Inc.'s Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 75.7% from $3.9M a year earlier and eps declined 22.5% from $-0.40.

Where can I find Vivos Therapeutics, Inc.'s Q3 2025 SEC filings?

You can read the 8-K earnings release (0001493152-25-024289) and the 10-Q periodic report (0001493152-25-024253) directly on SEC EDGAR. The filing index links above go to sec.gov.